Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers

• Status: Completed
• Trial end date: 2014-09-01
• Target enrollment: 0
• Participant gender: All

Summary

This is an open label study of subjects who have failed Protocol PGN-1300. Adult subjects (greater than 18 years old) who present with a mildly infected diabetic foot ulcer (IDSA criteria) having full thickness (i.e., through the dermis but not involving joint capsule, tendon, and bone) and have failed PGN-1300. Subjects must also provide informed consent and meet all other entry criteria to be enrolled and receive PluroGel PN.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: PluroGen Therapeutics, Inc
• Collaborator: Arkios BioDevelopment International

Criteria

Inclusion Criteria:

• Subjects who have failed treatment on Protocol PGN-1300X

Exclusion Criteria:

-